We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.4B
AUM Growth
+$153M
(+0.69%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-4.8%
Top 10 Holdings %
Top 10 Hldgs %
13.8%
Holding
1,474
New
155
Increased
445
Reduced
544
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Conagra Brands
CAG
|
+$72.5M |
| 2 |
ConocoPhillips
COP
|
+$70M |
| 3 |
PepsiCo
PEP
|
+$60.2M |
| 4 |
TJX Companies
TJX
|
+$57.6M |
| 5 |
Dollar General
DG
|
+$57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$122M |
| 2 |
Starbucks
SBUX
|
+$69M |
| 3 |
Altria Group
MO
|
+$64.7M |
| 4 |
RTX Corp
RTX
|
+$63.2M |
| 5 |
UBS Group
UBS
|
+$56.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.92% |
| 2 | Technology | 12.76% |
| 3 | Miscellaneous | 10.7% |
| 4 | Financials | 10.43% |
| 5 | Industrials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Acadia Realty Trust
AKR
$2.7B
| $7.33M | 0.03% |
206,305
+56,800
| +38% | +$1.94M |
|
452
Crane NXT
CXT
$2.74B
| $7.33M | 0.03% |
371,967
-52,973
| -12% | -$1.03M |
|
453
CME Group
CME
$98.9B
| $7.29M | 0.03% |
74,800
+800
| +1% | +$75.6K |
|
|
SCHW
454
Charles Schwab
SCHW
$186B
| $7.28M | 0.03% |
287,587
+10,290
| +4% | +$292K |
|
|
ACHN
455
DELISTED
Achillion Pharmaceuticals
ACHN
| $7.28M | 0.03% |
932,784
-38,173
| -4% | -$327K |
|
|
UMPQ
456
DELISTED
Umpqua Holdings Corp
UMPQ
| $7.19M | 0.03% |
464,900
+7,300
| +2% | +$114K |
|
457
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.8B
| $7.19M | 0.03% |
148,940
-2,510
| -2% | -$126K |
|
|
ONCE
458
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $7.17M | 0.03% |
140,278
-107,510
| -43% | -$4.59M |
|
459
ScottsMiracle-Gro
SMG
$3.27B
| $7.17M | 0.03% |
+102,500
| New | +$7.12M |
|
|
ALDR
460
DELISTED
Alder Biopharmaceuticals
ALDR
| $7.16M | 0.03% |
286,620
+33,441
| +13% | +$905K |
|
|
QEP
461
DELISTED
QEP RESOURCES, INC.
QEP
| $7.16M | 0.03% |
+405,900
| New | +$7.01M |
|
|
TUP
462
DELISTED
Tupperware Brands Corporation
TUP
| $7.13M | 0.03% |
126,700
-17,460
| -12% | -$996K |
|
|
MPT
463
Medical Properties Trust
MPT
$2.11B
| $7.1M | 0.03% |
466,579
-24,900
| -5% | -$352K |
|
|
AHL
464
DELISTED
ASPEN Insurance Holding Limited
AHL
| $7.1M | 0.03% |
153,000
+28,200
| +23% | +$1.32M |
|
465
State Street SPDR S&P 500 ETF Trust
SPY
$799B
| $7.08M | 0.03% |
33,817
+40
| +0.1% | +$8.3K |
|
|
BLUE
466
DELISTED
bluebird bio
BLUE
| $7.08M | 0.03% |
12,627
+1,136
| +10% | +$643K |
|
467
Bath & Body Works
BBWI
$3.37B
| $7.05M | 0.03% |
129,885
-4,824
| -4% | -$283K |
|
468
Capital One
COF
$127B
| $7.03M | 0.03% |
110,631
-4,831
| -4% | -$336K |
|
469
Waters Corp
WAT
$41B
| $7M | 0.03% |
49,800
+1,400
| +3% | +$189K |
|
|
APC
470
DELISTED
Anadarko Petroleum
APC
| $6.99M | 0.03% |
131,229
-154,304
| -54% | -$7.82M |
|
471
Alnylam Pharmaceuticals
ALNY
$31.9B
| $6.97M | 0.03% |
125,662
+26,973
| +27% | +$1.7M |
|
472
East-West Bancorp
EWBC
$17.6B
| $6.92M | 0.03% |
202,521
| – | – |
|
473
Coherus Oncology
CHRS
$205M
| $6.88M | 0.03% |
407,592
-41,197
| -9% | -$773K |
|
474
International Flavors & Fragrances
IFF
$21.5B
| $6.88M | 0.03% |
54,600
+2,500
| +5% | +$309K |
|
475
Prudential Financial
PRU
$41.2B
| $6.87M | 0.03% |
96,223
-4,637
| -5% | -$350K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2016 Portfolio in Review
As of Q2 2016, Axa held 1,474 positions worth $22.4B, up 0.69% from $22.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa withdrew a net $1.08B in Q2 2016, closing 111 positions and reducing 544 holdings. Its most notable exit was MCGRAW-HILL FINANCIAL INC COM, an estimated $23.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, Axa opened a new position in Willis Towers Watson worth $32.3M.
- Axa's largest Q2 2016 buy was Willis Towers Watson: 260,003 shares worth $32.3M.
- Axa added most to Conagra Brands in Q2 2016, an estimated $72.5M increase.
- Axa's biggest Q2 2016 reduction was St Jude Medical, cutting an estimated $122M.
- Axa fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $23.5M.
- Axa's ten largest holdings make up 14% of its $22.4B portfolio in Q2 2016.
- Axa opened 155 new positions and closed 111 in Q2 2016.
- Axa's portfolio value rose 0.69% quarter-over-quarter to $22.4B.
Based on Axa's 13F filing for Q2 2016, filed 11 Aug 2016.